Cargando…

Abandon the Label of Clinically Insignificant Prostate Cancer

Detalles Bibliográficos
Autores principales:	Mertens, Laura S., van Leeuwen, Pim J., van der Poel, Henk G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Opinion: Open Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787776/ https://www.ncbi.nlm.nih.gov/pubmed/35106504 http://dx.doi.org/10.1016/j.euros.2021.12.012

Ejemplares similares

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Diagnosis of Clinically Significant Prostate Cancer Diagnosis Without Histological Proof in the Prostate-specific Membrane Antigen Era: The Jury Is Still Out
por: Wenzel, Mike, et al.
Publicado: (2022)

TREXIT Is Now: Should We Abandon the Transrectal Route for Prostate Biopsy? Yes
por: Grummet, Jeremy P., et al.
Publicado: (2021)

Virtual Prostate Biopsy with Prostate-specific Membrane Antigen and Magnetic Resonance Imaging: Closer to Reality in a Subgroup of Prostate Cancer Patients?
por: Pomykala, Kelsey L., et al.
Publicado: (2022)

Are Clinically Insignificant Prostate Cancers Really Insignificant among Korean Men?
por: Yeom, Chan Dong, et al.
Publicado: (2012)

Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?
por: Rouvière, Olivier, et al.
Publicado: (2022)

Active surveillance in intermediate risk prostate cancer: is it safe?
por: Henk, G. van der Poel, et al.
Publicado: (2016)

Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
por: McKay, Rana R.
Publicado: (2022)

Sentinel Lymph Node Biopsy: A Great Opportunity for Personalized Radiotherapy in Prostate Cancer
por: Supiot, Stéphane, et al.
Publicado: (2023)

“Dismantling Fixed Time, Variable Outcome Education: Abandoning ‘Ready or Not, Here they Come’ is Overdue”
por: Carraccio, Carol, et al.
Publicado: (2023)

Don’t abandon RCTs in IVF. We don’t even understand them
por: Wilkinson, J, et al.
Publicado: (2019)

Defining the Mycobiome in Bladder Cancer
por: Mercier, Benjamin D., et al.
Publicado: (2022)

Sex-specific Augmentation of Treatment Responses in Bladder Cancer
por: Chang, Kevin, et al.
Publicado: (2022)

Clinically Significant Prostate Cancer Diagnosis Without Histological Proof: A Possibility in the Prostate-specific Membrane Antigen Era?
por: Heetman, Joris G., et al.
Publicado: (2022)

Re-envisioning Patient Education and Public Awareness of Urological Cancers at the Time of the COVID-19 Pandemic
por: Pecoraro, Alessio, et al.
Publicado: (2022)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—Referee
por: van den Bergh, Roderick C.N., et al.
Publicado: (2021)

Early or Delayed Radical Cystectomy for High-risk Non–muscle-invasive Bladder Cancer: A Hard Dilemma to Solve
por: De Nunzio, Cosimo, et al.
Publicado: (2022)

Chromosomal catastrophe is a frequent event in clinically insignificant prostate cancer
por: Kovtun, Irina V., et al.
Publicado: (2015)

Identification of pathologically insignificant prostate cancer is not accurate in unscreened men
por: Shaw, G L, et al.
Publicado: (2014)

Lower Urinary Tract Symptoms: A Unique Platform for Urologists’ Fundamental Role in Overall Health
por: Monaghan, Thomas F., et al.
Publicado: (2020)

Management of Favorable-risk Advanced Renal Cell Carcinoma: Is Dual Therapy the Answer?
por: Kartolo, Adi, et al.
Publicado: (2021)

Prehabilitation Programs Before Radical Prostatectomy: An Interesting Approach that Merits Further Evaluation
por: Isbarn, Hendrik
Publicado: (2020)

Management of Late Relapses in Metastatic Testicular Germ Cell Tumors: Still a Challenge
por: Heidenreich, Axel
Publicado: (2021)

Orphaned Side-effects After Robot-assisted Radical Prostatectomy: Is the Retzius-sparing Approach Superior to the Standard Approach or Are the Data Just Not Mature Enough?
por: Würnschimmel, Christoph, et al.
Publicado: (2021)

A Precision Urodynamic Diagnosis is Essential for Successful Treatment of Lower Urinary Tract Dysfunction
por: Kuo, Hann-Chorng
Publicado: (2022)

Checklist for Transurethral Resection of Bladder Tumor (TURBT): A Step Forward in the Standardization for TURBT Reporting
por: Martínez-Piñeiro, Luis
Publicado: (2022)

The Metaverse in Urology: Ready for Prime Time. The ESUT, ERUS, EULIS, and ESU Perspective
por: Checcucci, Enrico, et al.
Publicado: (2022)

Evolution and Implications of the Novel CAMUS Reporting and Classification System: From Rationale to End Product
por: Soliman, Christopher, et al.
Publicado: (2023)

The Decision to Surgically Resect Recurrent Renal Cell Carcinoma: More Evidence that Careful Case Selection by Surgeons Is Associated with Better Survival
por: Russo, Paul
Publicado: (2023)

Superfast Magnetic Resonance Imaging-based Diagnostic Pathway for Prostate Cancer
por: Paulino Pereira, Leonor Jane, et al.
Publicado: (2022)

Destiny of Insignificance
por: Sillitoe, Alan
Publicado: (1966)

TREXIT Is Now: Should We Abandon the Transrectal Route for Biopsy? A Three-continent Debate—No
por: Olivier, Jonathan, et al.
Publicado: (2021)

Radiotherapy is the Preferred Primary Tumor Treatment in Oligometastatic Prostate Cancer
por: van Moorselaar, R. Jeroen A., et al.
Publicado: (2022)

Rule-based versus probabilistic selection for active surveillance using three definitions of insignificant prostate cancer
por: Venderbos, Lionne D. F., et al.
Publicado: (2015)

LMTK2 as Potential Biomarker for Stratification between Clinically Insignificant and Clinically Significant Prostate Cancer
por: Vezelis, Alvydas, et al.
Publicado: (2021)

Abandoned frozen embryos in Argentina: a committee opinion
por: Lima, Natacha Salomé, et al.
Publicado: (2019)

Our Cosmic Insignificance
por: Kahane, Guy
Publicado: (2014)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
por: Donswijk, Maarten L., et al.
Publicado: (2020)

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
por: Hagens, Marinus J., et al.
Publicado: (2022)

Photowalk 2018 - Lucrees VanGroningen
por: VanGroningen, Lucrees
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_6qlh6brehgf94htped9trksrm2